Make your money go further for just 25p per day

AIM IHT

Coronavirus impact: 30 March - a hint of resilience

Bioventixantibody

The week has started with yet more dividend postponements and cancellations but also some fabulous results from one of the most resilient companies on the stock market.


Bioventix: reliability shines through

Bioventix (LON:BVXP), the developer of high-affinity monoclonal antibodies for applications in clinical diagnostics, has announced excellent interim results for the six months ending 31 December 2019. Revenue rose 21% to £5.3m and pre-tax profit was up 31% to £4.3m. The operating cash inflow was £4m with period end cash £5.5m - cashflows are crucial companies attempt to battle a the period of lockdown.

But Bioventix isn't facing as many challenges as other companies…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Alpha Group International

Upgrades | Downgrades | Another takeover

24/07/2025 · Company Insights

Results and updates from AIM are coming think and fast. While the majority are positive, the…


CMA relief | Software success | Offers galore

07/05/2025 · Company Insights

The offers continue to come in for UK companies with one of our Stonking Small Caps…


More on Bioventix

Tough end to the quarter | Avenues for growth

31/03/2025 · Company Insights

The escalating trade war sees markets tumble at the close of the quarter. As is generally…


Another AIM offer | Results underwhelm | Tough to value

28/10/2024 · Company Insights

An important week for AIM begins with yet another small AIM company receiving an offer, not…


More on Flowtech Fluidpower Plc

A distinct lack of Swiss precision

26/01/2021 · Company Insights

Updates covered here include those from a highly-rated creator of textile treatments, which was unfortunately unable…


Coronavirus impact: 8 Sept - fabulous results from this AIM blue chip and much more

08/09/2020 · Company Insights

There were a large number of announcements today, including fabulous results from a fast growing provider of…


More on James Latham

Playing it straight | Powering-up | Social influence

27/06/2025 · Company Insights

A software group covered here has paid top dollar for a US-based influencer, affiliate and referral…


Benefit from the downturn | 8% dividend yield

29/11/2024 · Company Insights

News covered here includes our assessment of results from one of AIM’s oldest company. This well-managed business…


More Company Insights

Hostel delights | Franchise mystery | Steady as ever

Neuroscience company with exciting potential

01/08/2025 · Cambridge Cognition

Sign-up to our free email updates

SIGN UP